Taiwan FDA registration 2afc0f45726e06d88b7f9c5dba159aba

"Retex" liquid cerebrospinal fluid quality tube fluid

TW: "瑞德士" 液態腦脊髓液品管液

Taiwan·Risk Class 2·RANDOX LABORATORIES LTD·Registered May 31, 2022 – May 31, 2027Active

Registration details

Analysis ID: 2afc0f45726e06d88b7f9c5dba159aba
Customs Code: DHA05603565200

Company information

Manufacturer: RANDOX LABORATORIES LTD
Manufacturer Country: United Kingdom
Authorized Representative: KUO'S YUAN IN ENTERPRISE CO., LTD.

Product details

Intended Use: This product is intended for in vitro diagnostic use, quality control of cerebrospinal fluid assay in clinical biochemical systems. This product can be used to monitor the accuracy and reproducibility of cerebrospinal fluid assays.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1660 Quality control materials (analytical and non-analytical)
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: May 31, 2022
Expiry Date: May 31, 2027

About this record

Access comprehensive regulatory information for "Retex" liquid cerebrospinal fluid quality tube fluid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2afc0f45726e06d88b7f9c5dba159aba and manufactured by RANDOX LABORATORIES LTD. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.